M&A Fury Hits and It's Only Just January


We are still only in January and Celgene and Sanofi have already made a combined $20B in M&A deals. Sanofi has acquired Biogen's spinoff Bioverativ for about $11.6 billion. The third time is the charm apparently, having lost out on bids for Medivation to Pfizer and to J&J for Actelion. A little more than two years after taking a $1 billion stake in Juno, Celgene has snapped up the rest of the company in a $9 billion deal.

Here's a roundup of these stories and other top deals and partnerships from the past month.

Read More From Karl Thiel:
Get Ready for the M&A Explosion


Back to news